Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries

Kevin Retailleau, Eric J. Belin De Chantemèle, Sébastien Chanoine, Anne Laure Guihot, Emilie Vessières, Bertrand Toutain, Sébastien Faure, Zsolt Bagi, Laurent Loufrani, Daniel Henrion

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Angiotensin II has a key role in the control of resistance artery tone and local blood flow. Angiotensin II possesses 2 main receptors. Although angiotensin II type 1 receptor is well known and is involved in the vasoconstrictor and growth properties of angiotensin II, the role of the angiotensin II type 2 receptor (AT2R) remains much less understood. Although AT2R stimulation induces vasodilatation in normotensive rats, it induces vasoconstriction in pathological conditions involving oxidative stress and cyclooxygenase 2 expression. Thus, we studied the influence of cyclooxygenase 2 on AT2R-dependent tone in diabetes mellitus. Mesenteric resistance arteries were isolated from Zucker diabetic fatty (ZDF) and lean Zucker rats and studied using in vitro using wire myography. In ZDF rats, AT2R-induced dilation was lower than in lean rats (11% versus 21% dilation). Dilation in ZDF rats returned to the control (lean rats) level after acute superoxide reduction (Tempol and apocynin), cyclooxygenase 2 inhibition (NS398), or thromboxane A2 synthesis inhibition (furegrelate). Cyclooxygenase 2 expression and superoxide production were significantly increased in ZDF rat arteries compared with arteries of lean rats. After chronic treatment with Tempol, AT2R-dependent dilation was equivalent in ZDF and lean rats. Chronic treatment of ZDF rats with NS398 also restored AT2R-dependent dilation to the control (lean rats) level. Plasma thromboxane B2 (thromboxane A2 metabolite), initially high in ZDF rats, was decreased by chronic Tempol and by chronic NS398 to the level found in lean Zucker rats. Thus, in type 2 diabetic rats, superoxide and thromboxane A2 reduced AT2R-induced dilation. These findings are important to take into consideration when choosing vasoactive drugs for diabetic patients.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalHypertension
Volume55
Issue number2
DOIs
StatePublished - Feb 1 2010

Fingerprint

Angiotensin Type 2 Receptor
Thromboxane A2
Cyclooxygenase 2
Vasodilation
Reactive Oxygen Species
Arteries
Dilatation
Superoxides
Angiotensin II
Zucker Rats
Myography
Thromboxane B2
Angiotensin Type 1 Receptor
Mesenteric Arteries
Vasoconstrictor Agents
Vasoconstriction

Keywords

  • Angiotensin II
  • Angiotensin II type 2 receptor
  • Cyclooxygenase 2
  • Oxidative stress
  • Resistance arteries
  • Thromboxane A2
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. / Retailleau, Kevin; Belin De Chantemèle, Eric J.; Chanoine, Sébastien; Guihot, Anne Laure; Vessières, Emilie; Toutain, Bertrand; Faure, Sébastien; Bagi, Zsolt; Loufrani, Laurent; Henrion, Daniel.

In: Hypertension, Vol. 55, No. 2, 01.02.2010, p. 339-344.

Research output: Contribution to journalArticle

Retailleau, Kevin ; Belin De Chantemèle, Eric J. ; Chanoine, Sébastien ; Guihot, Anne Laure ; Vessières, Emilie ; Toutain, Bertrand ; Faure, Sébastien ; Bagi, Zsolt ; Loufrani, Laurent ; Henrion, Daniel. / Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. In: Hypertension. 2010 ; Vol. 55, No. 2. pp. 339-344.
@article{0bbec1584fb54ee6895e90388aeefee4,
title = "Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries",
abstract = "Angiotensin II has a key role in the control of resistance artery tone and local blood flow. Angiotensin II possesses 2 main receptors. Although angiotensin II type 1 receptor is well known and is involved in the vasoconstrictor and growth properties of angiotensin II, the role of the angiotensin II type 2 receptor (AT2R) remains much less understood. Although AT2R stimulation induces vasodilatation in normotensive rats, it induces vasoconstriction in pathological conditions involving oxidative stress and cyclooxygenase 2 expression. Thus, we studied the influence of cyclooxygenase 2 on AT2R-dependent tone in diabetes mellitus. Mesenteric resistance arteries were isolated from Zucker diabetic fatty (ZDF) and lean Zucker rats and studied using in vitro using wire myography. In ZDF rats, AT2R-induced dilation was lower than in lean rats (11{\%} versus 21{\%} dilation). Dilation in ZDF rats returned to the control (lean rats) level after acute superoxide reduction (Tempol and apocynin), cyclooxygenase 2 inhibition (NS398), or thromboxane A2 synthesis inhibition (furegrelate). Cyclooxygenase 2 expression and superoxide production were significantly increased in ZDF rat arteries compared with arteries of lean rats. After chronic treatment with Tempol, AT2R-dependent dilation was equivalent in ZDF and lean rats. Chronic treatment of ZDF rats with NS398 also restored AT2R-dependent dilation to the control (lean rats) level. Plasma thromboxane B2 (thromboxane A2 metabolite), initially high in ZDF rats, was decreased by chronic Tempol and by chronic NS398 to the level found in lean Zucker rats. Thus, in type 2 diabetic rats, superoxide and thromboxane A2 reduced AT2R-induced dilation. These findings are important to take into consideration when choosing vasoactive drugs for diabetic patients.",
keywords = "Angiotensin II, Angiotensin II type 2 receptor, Cyclooxygenase 2, Oxidative stress, Resistance arteries, Thromboxane A2, Type 2 diabetes mellitus",
author = "Kevin Retailleau and {Belin De Chantem{\`e}le}, {Eric J.} and S{\'e}bastien Chanoine and Guihot, {Anne Laure} and Emilie Vessi{\`e}res and Bertrand Toutain and S{\'e}bastien Faure and Zsolt Bagi and Laurent Loufrani and Daniel Henrion",
year = "2010",
month = "2",
day = "1",
doi = "10.1161/HYPERTENSIONAHA.109.140236",
language = "English (US)",
volume = "55",
pages = "339--344",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries

AU - Retailleau, Kevin

AU - Belin De Chantemèle, Eric J.

AU - Chanoine, Sébastien

AU - Guihot, Anne Laure

AU - Vessières, Emilie

AU - Toutain, Bertrand

AU - Faure, Sébastien

AU - Bagi, Zsolt

AU - Loufrani, Laurent

AU - Henrion, Daniel

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Angiotensin II has a key role in the control of resistance artery tone and local blood flow. Angiotensin II possesses 2 main receptors. Although angiotensin II type 1 receptor is well known and is involved in the vasoconstrictor and growth properties of angiotensin II, the role of the angiotensin II type 2 receptor (AT2R) remains much less understood. Although AT2R stimulation induces vasodilatation in normotensive rats, it induces vasoconstriction in pathological conditions involving oxidative stress and cyclooxygenase 2 expression. Thus, we studied the influence of cyclooxygenase 2 on AT2R-dependent tone in diabetes mellitus. Mesenteric resistance arteries were isolated from Zucker diabetic fatty (ZDF) and lean Zucker rats and studied using in vitro using wire myography. In ZDF rats, AT2R-induced dilation was lower than in lean rats (11% versus 21% dilation). Dilation in ZDF rats returned to the control (lean rats) level after acute superoxide reduction (Tempol and apocynin), cyclooxygenase 2 inhibition (NS398), or thromboxane A2 synthesis inhibition (furegrelate). Cyclooxygenase 2 expression and superoxide production were significantly increased in ZDF rat arteries compared with arteries of lean rats. After chronic treatment with Tempol, AT2R-dependent dilation was equivalent in ZDF and lean rats. Chronic treatment of ZDF rats with NS398 also restored AT2R-dependent dilation to the control (lean rats) level. Plasma thromboxane B2 (thromboxane A2 metabolite), initially high in ZDF rats, was decreased by chronic Tempol and by chronic NS398 to the level found in lean Zucker rats. Thus, in type 2 diabetic rats, superoxide and thromboxane A2 reduced AT2R-induced dilation. These findings are important to take into consideration when choosing vasoactive drugs for diabetic patients.

AB - Angiotensin II has a key role in the control of resistance artery tone and local blood flow. Angiotensin II possesses 2 main receptors. Although angiotensin II type 1 receptor is well known and is involved in the vasoconstrictor and growth properties of angiotensin II, the role of the angiotensin II type 2 receptor (AT2R) remains much less understood. Although AT2R stimulation induces vasodilatation in normotensive rats, it induces vasoconstriction in pathological conditions involving oxidative stress and cyclooxygenase 2 expression. Thus, we studied the influence of cyclooxygenase 2 on AT2R-dependent tone in diabetes mellitus. Mesenteric resistance arteries were isolated from Zucker diabetic fatty (ZDF) and lean Zucker rats and studied using in vitro using wire myography. In ZDF rats, AT2R-induced dilation was lower than in lean rats (11% versus 21% dilation). Dilation in ZDF rats returned to the control (lean rats) level after acute superoxide reduction (Tempol and apocynin), cyclooxygenase 2 inhibition (NS398), or thromboxane A2 synthesis inhibition (furegrelate). Cyclooxygenase 2 expression and superoxide production were significantly increased in ZDF rat arteries compared with arteries of lean rats. After chronic treatment with Tempol, AT2R-dependent dilation was equivalent in ZDF and lean rats. Chronic treatment of ZDF rats with NS398 also restored AT2R-dependent dilation to the control (lean rats) level. Plasma thromboxane B2 (thromboxane A2 metabolite), initially high in ZDF rats, was decreased by chronic Tempol and by chronic NS398 to the level found in lean Zucker rats. Thus, in type 2 diabetic rats, superoxide and thromboxane A2 reduced AT2R-induced dilation. These findings are important to take into consideration when choosing vasoactive drugs for diabetic patients.

KW - Angiotensin II

KW - Angiotensin II type 2 receptor

KW - Cyclooxygenase 2

KW - Oxidative stress

KW - Resistance arteries

KW - Thromboxane A2

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=74949142724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949142724&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.109.140236

DO - 10.1161/HYPERTENSIONAHA.109.140236

M3 - Article

C2 - 20026767

AN - SCOPUS:74949142724

VL - 55

SP - 339

EP - 344

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -